CPC A61K 31/4545 (2013.01) [A61K 31/496 (2013.01); A61P 37/06 (2018.01)] | 18 Claims |
1. A method for treating a mammal having an autoimmune disease, wherein said method comprises administering a SCD1 polypeptide inhibitor to said mammal, wherein said SCD1 polypeptide inhibitor is a compound having Formula (II):
or pharmaceutically acceptable salt thereof;
wherein:
R1 is halo;
X is —(C═O)NR4—,
Y is
and
R2, R3, and R4 are each independently H or an unsubstituted C1-6alkyl.
|